Displaying drugs 551 - 575 of 615 in total
D-Eritadenine
Experimental
9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
Experimental
Oxypurinol
Oxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol.
Investigational
Seliciclib
R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated cells. Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex...
Investigational
GS 0573
Investigational
Filociclovir
Filociclovir is under investigation in clinical trial NCT01433835 (Safety and Pharmacokinetics of Single Oral Doses of Filociclovir in Healthy Volunteers).
Investigational
Rabacfosadine
Rabacfosadine has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin's Lymphoma, and Chronic Lymphocytic Leukemia.
Investigational
5'-S-ethyl-5'-thioadenosine
Experimental
GW-493838
GW493838 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Pinometostat
Pinometostat has been used in trials studying the treatment of Leukemia, Acute Leukemias, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Acute Lymphocytic Leukemia, among others.
Investigational
2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol
Experimental
Olomoucine
Experimental
9-Methylguanine
Experimental
Purvalanol
Experimental
Displaying drugs 551 - 575 of 615 in total